화학공학소재연구정보센터

Chemical Week

Chemical Week, Vol.165, No.33 Entire volume, number list
ISSN: 0009-272X (Print) 

In this Issue (36 articles)

7 - 7 No more Chinese petchem JV's?
Young I
11 - 11 More firms issue earnings warnings
Walsh K
11 - 11 Hurricane Isabel has litle impact on East Coast plants
Hwee P
13 - 13 Millennium issues earnings warning;'Reviews' flavors unit
Walsh K
13 - 13 More margin pressure in chlor-alkali
Sim PH
14 - 14 P&G to outsource global HR to IBM
D'Amico E
14 - 14 Eastman chemical to cut more jobs
Walsh K
16 - 16 Socma adopts Responsible Care Management System
D'Amico E
16 - 16 Nova proceeds with expansion of styrene capacity at Bayport
Scott A
19 - 19 Solvay details US chemicals reorganization
Sim PH
19 - 19 Monsanto says seeds and traits profits will eclipse roundup
Westervelt R
19 - 19 Court rejects Baycol class-action suit
[Anonymous]
20 - 20 Sabic revives plans for cracker and derivatives units in Europe
Alperowicz N
20 - 20 Green light near for propylene pipeline
Alperowicz N
22 - 22 Degussa expands carbon black JV in China
Scott A, Wood A
22 - 22 Hyosung to raise spandex capacity in China; Plans plant in Europe
Westervelt R
27 - 27 Borealis aiming for better returns
Alperowicz N
35 - 35 Producers grapple with market volatility - Feedstock fluctuations cause severe margin swings
Young I
37 - 37 Nordic region weathers the cold
Seewald N
39 - 39 Great Lakes to receive supplies from dead sea bromine
D'Amico E
39 - 39 Procter & Gamble to build facility in Malaysia
Walsh K
40 - 40 Terra, restarts ammonia plant in Arkansas
Sim PH
40 - 40 Strong housing market boosts prospects for PVC price hike
Sim PH
41 - 41 Bisohenola
[Anonymous]
44 - 44 Dow gets back on track - Stavropoulos's return heralds better results
Westervelt R
46 - 46 Firms gear up for third-party audits - A management system approach to responsible care
Sissell K
55 - 55 Pharmaceutical ingredients - September 24, 2003 - Tough times for intermediates firms
Scott A
58 - 58 Biopharma manufacturing capacity comes into balance
Scott A
62 - 62 Custom firms focus on cost-cutting efforts
Scott A
72 - 72 FDA seeks to make drug manufacture less risky
West D
76 - 76 Finding efficiencies in continuous intermediates production
Houlton S
84 - 84 Industry continues to expand rapidly
Young I
S3 - S3 Sabic-in third phase of global strategy
Alperowicz N
S8 - S8 Company profile - Basell - Basell takes leadership to a new level
[Anonymous]
S10 - S10 Middle East regional review - Iran - moves ahead with bold expansion plans
[Anonymous]
S23 - S23 Middle East regional review - Uhde leads the fertilizer field
[Anonymous]